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1. Direct link to deposited data {#s0005}
================================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66517>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Constructs {#s0015}
---------------

We used MAPS technology to identify sRNA(s) interacting with both internal transcribed spacers (ITS) of *metZ--metW--metV* tRNA transcript [@bb0025]. Because ITS^*metZ--metW*^ and ITS^*metW--metV*^ have similar but imperfectly repeated sequences (4 mismatches/33 nucleotides), we cloned both sequences individually, under the control of a pBAD promoter (arabinose-inducible promoter). A T7 terminator was added at the end of both ITS to interrupt transcription.

We fused the 5′-end of ITS^*metZ--metW*^ and ITS^*metW--metV*^ with bacteriophage MS2 RNA stemloops, which are bound by the MS2 coat protein with high specificity. This highly specific interaction was previously shown to allow affinity co-purification of sRNA-bound proteins from bacterial extracts [@bb0010].

As controls, we used untagged ITS^*metZ--metW*^ and ITS^*metW--metV*^ expressed under the same conditions.

We used Northern blot analysis to verify that the MS2-ITS^*metZ--metW*^ construct is expressed at a level similar to ITS^*metZ--metW*^ and at the expected molecular weight. Similar results were obtained with MS2-ITS^*metW--metV*^ and ITS^*metW--metV*^.

2.2. Growth conditions {#s0020}
----------------------

Cells from an overnight culture grown in rich medium (LB) supplemented with 50 μg/ml ampicillin were diluted 1/1000 in the same fresh medium. For each construct, cells were harvested in exponential (OD~600 nm~ = 0.5; 50 mL) and stationary (OD~600 nm~ = 1; 50 mL) phases.

2.3. Affinity purification {#s0025}
--------------------------

Affinity purification assays were performed as described in Desnoyers and Masse [@bb0015] with some modifications (see Fig. S1 in Lalaouna et al. [@bb0025] for a schematic representation of MAPS technology). As indicated above, the bacterial strains were grown to an OD~600 nm~ of 0.5 or 1, at which point 0.1% arabinose was added to induce expression from pBAD promoter during 10 min. Cells were then chilled for 10 min on ice. Total RNA was extracted from 600 μL of culture (input) using the hot-phenol procedure [@bb0005]. The remaining cells were then centrifuged, resuspended in 1 mL of buffer A (20 mM Tris--HCl pH 8.0, 150 mM KCl, 1 mM MgCl2, 1 mM DTT), and centrifuged again.

At this point, cells carrying MS2-ITS^*metZ--metW*^ and MS2-ITS^*metW--metV*^ were mixed together. The same was done with cells carrying ITS^*metZ--metW*^ and ITS^*metW--metV*^. Cells were resuspended in 3 mL of buffer A and lysed using a French Press (430 psi, four times). Lysate was then cleared by centrifugation (17,000 *g*, 30 min, 4 °C). The soluble fraction was subjected to affinity chromatography (all steps performed at 4 °C). The column was prepared by adding 100 μL of amylose resin (New England Biolabs) to Bio-Spin disposable chromatography columns (Bio-Rad). The column was then washed with 3 mL of buffer A. Next, 200 pmol of MS2-MBP protein was immobilized on the amylose resin, and the column was washed with 2 mL of buffer A. The cleared lysate was then loaded onto the column, which was washed with 8 mL of buffer A. RNA was eluted from the column with 1 mL of buffer A containing 15 mM maltose. Eluted RNA was extracted with phenol--chloroform, followed by ethanol (3 vol) precipitation of the aqueous phase in the presence of 20 mg of glycogen. RNA samples were then analyzed by Northern blot as described in Lalaouna et al. [@bb0025].

2.4. RNA sequencing {#s0030}
-------------------

After MS2 affinity purification, samples were treated with TURBO™DNase (Ambion). Again, RNA was extracted using phenol--chloroform, followed by ethanol (3 vol) precipitation of the aqueous phase in the presence of 20 mg of glycogen.

RNA quality and quantity assessments were performed on Agilent Nano Chip on the bioanalyzer 2100. The RNAseq library was then built using NEBNext Small RNA Library Prep set E7330S kit from 300 ng total RNA. Size selection was performed with Agencourt AMPure XP beads. Library quality was assessed using Agilent DNA HS Chip. Library quantification was performed by qPCR following Illumina Kappa library quantification protocol. Pooled libraries were sequenced 2 × 50 bp paired-end reads using Illumina MiSeq with 150v3 reagent kit.

2.5. Data processing {#s0035}
--------------------

We used Galaxy Project [@bb0020] and UCSC Microbial GenomeBrowser [@bb0035] to analyze and visualize data. We used FASTQ Groomer (version 1.0.4) to verify and convert FASTQ files. The quality of raw sequence data was controlled with FastQC:Read QC (version 0.52). Then, reads were aligned to the Escherichia coli K12 genome assembly using Map with Bowtie for Illumina (version 1.1.2). We used Create a BedGraph of genome coverage (version 0.1.0) to visualize reads on *E. coli* MG1655 genome with UCSC Microbial GenomeBrowser. Results obtained for RybB and MicF sRNA are represented in [Fig. 1](#f0005){ref-type="fig"}.

Finally, we assigned reads to gene by comparing mapped regions of reads with *E. coli* gene positions (extracted from GenBank). The processed data files is a tab-delimited text file which includes normalized reads for each sample and MS2-ITS^*metZWV*^/ITS^*metZWV*^ ratio. Here, Read counts were normalized by coverage according to Oshlack et al. [@bb0030].
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![RNAseq data visualized using GenomeBrowser software. (A) RybB (b4417) and (B) MicF (b4439) sRNAs are highly enriched in MS2-ITS^*metZWV*^ pull-down.](gr1){#f0005}
